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Abstract
Background: Paramyosin is a thick myofibrillar protein found exclusively in invertebrates. Evidence suggested that
paramyosin from helminths serves not only as a structural protein but also as an immunomodulatory agent. We previously
reported that recombinant Trichinella spiralis paramyosin (Ts-Pmy) elicited a partial protective immunity in mice. In this
study, the ability of Ts-Pmy to bind host complement components and protect against host complement attack was
investigated.
Methods and Findings: In this study, the transcriptional and protein expression levels of Ts-Pmy were determined in T.
spiralis newborn larva (NBL), muscle larva (ML) and adult worm developmental stages by RT-PCR and western blot analysis.
Expression of Ts-Pmy at the outer membrane was observed in NBL and adult worms using immunogold electron
microscopy and immunofluorescence staining. Functional analysis revealed that recombinant Ts-Pmy(rTs-Pmy) strongly
bound to complement components C8 and C9 and inhibited the polymerization of C9 during the formation of the
membrane attack complex (MAC). rTs-Pmy also inhibited the lysis of rabbit erythrocytes (ER) elicited by an alternative
pathway-activated complement from guinea pig serum. Inhibition of native Ts-Pmy on the surface of NBL with a specific
antiserum reduced larvae viability when under the attack of complement in vitro. In vivo passive transfer of anti-Ts-Pmy
antiserum and complement-treated larvae into mice also significantly reduced the number of larvae that developed to ML.
Conclusion: These studies suggest that the outer membrane form of T. spiralis paramyosin plays an important role in the
evasion of the host complement attack.
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Introduction
Trichinellosis is one of the common parasitic zoonoses and is a
serious public threat in both developing and developed countries
[1-6]. Trichinella spiralis (T. spiralis) infection is initiated by the
consumption of meat contaminated with infective muscle larvae
(ML). With the aid of host gastric juice, ML are released from cysts
and migrate to the small intestine where they develop into adult
worms in 2–3 days. Five days post-infection, gravid females begin
to produce newborn larvae (NBL), which penetrate the intestinal
mucosa and enter the lymphatic vessels and bloodstream [7]. NBL
travel through capillaries to various organs and finally invade the
muscles, where they form cysts. During the life cycle of T. spiralis in
the host, all developmental stages are exposed to host complement,
which is the first line of defense against pathogenic organisms and
is a functional bridge between the innate and adaptive immune
responses [8].
The ability to evade complement attack is essential for the survival
of parasites within their respective hosts [9]. As early as 1911, the
presence of complement-fixing antigens from larvae of T. spiralis was
reported in antiformin extracts of pepsin-digested rat muscle [10].
Complement -fixing antigens have since been used to diagnosis of
trichinosis of trichinellosis [11,12]. Subsequent studies have reported
that the complement elements C3, C5 [13], C1q, C8 and C9 [14,15]
directly bind the ML of T. spiralis. All three stages of T. spiralis are
capable of activating complement via the classical or alternative
pathways [14], or the lectin pathway [16]. However, it is still
unknown whether the activation of the complement is detrimental or
beneficial to the parasite. NBL might be the most potent activators
[13]. Molecules or structures on the outermost cuticle/epicuticle of
the parasite directly bind complement and appear to protect the
parasite from an attack by inhibiting the formation of the membrane
attack complex (MAC) [14,15]. Rats with normal levels of C6 or
those with a C6-deficiency have similar susceptibilities to infection by
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suggesting that T. spiralis has efficient mechanisms for protecting
against complement attack [15]. However, the precise molecular
basis for this resistance is still unknown.
Paramyosin is a thick myofibrillar protein found exclusively in
invertebrates [17]. Experimental evidence has shown that para-
myosin from helminths serves not only as a structural protein but also
as an immunomodulatory agent [18–22]. It has been reported that
paramyosin from Taenia solium inhibits C1 function [18]. Paramyosin
fromSchistosoma mansoni acts as animmunologicaldefense molecule by
binding C1q [18], the Fc fragment of IgG [19], C8 and C9 [20–21].
Recently, paramyosin from Clonorchis sinensis was shown to bind both
human collagen and C9 [22]. In our previous study, a full-length
cDNA encoding T. spiralis paramyosin (Ts-Pmy) was cloned by
immunoscreening an adult T. spiralis cDNA library with infected
immune sera [23], Recombinant Ts-Pmy (rTs-Pmy) elicited partial
protective immunity against a T. spiralis larval challenge in BALB/c
mice [24]. In the present study, we investigated ability of rTs-Pmy to
bind to host complement components and to protect against host
complement attack. Our data show that rTs-Pmy binds complement
components C8 and C9 and inhibits the complement-mediated
killing of NBL, providing more evidence that Ts-Pmy plays an
importantroleintheevasionofthehostimmuneresponsetofacilitate
the survival of T. spiralis in its host.
Materials and Methods
Animals
All experimental animals were purchased from Laboratory
Animal Services Center of Capital Medical University (Beijing,
China). All experimental procedures were reviewed and approved
by the Capital Medical University Animal Care and Use
Committee and were consistent with the NIH Guidelines for the
Care and Use of Laboratory Animals.
Parasites and antigen preparation
T. spiralis (ISS 533 strain) was maintained in female ICR mice.
ML were recovered from the muscles of infected mice by a
standard pepsin/hydrochloric acid digestion method as described
previously [14]. Adult worms were obtained from the intestine of a
rat infected orally with 800 T. spiralis ML [25]. NBL were obtained
from fertile female adult worms cultured overnight in RPMI 1640
at 37uC. Crude somatic extracts of the different stages of T. spiralis
were prepared by conventional methods [26], and the protein
concentration was determined by the BCA assay (Pierce,USA).
RT-PCR analysis
Total RNA was extracted from T. spiralis ML, adult worms and
NBL with an RNAeasy mini kit (Qiagen, Germany) according to
the manufacturer’s instructions. Total first-strand cDNAs were
reverse transcribed from the total mRNAs using a Sensiscript
Reverse Transcription kit (Qiagen, Germany). The specific
forward primer (59- ACC AAC TGA GGG CTT TGC A-39)
and reverse primer (5-9 AAT ATT CAT GTC CTT CTT CCA
TCA C-39), based on Ts-Pmy coding sequence of 1830–2730 bp,
were used to amplify Ts-pmy cDNA fragments (900 bp) from
reverse transcribed total cDNA from different developmental
stages of T. spiralis using a PCR kit (TaKaRa, China). Reactions
without the addition of reverse transcriptase were used as negative
controls. The amplified products were analyzed in 2% agarose gels
and stained with DNA Green (Tandz, USA).
Expression of recombinant paramyosin (rTs-Pmy) and
preparation of the anti-rTs-Pmy antibody
rTs-Pmy was expressed in E. coli BL-21(DE3) using the pET-28a
expression system (Novagen, USA) and purified with Ni-affinity
chromatography (Qiagen, USA), as described previously [23]. The
antiserum against rTs-pmy was raised in rabbits immunized three
times with 150 mgr Ts-Pmy. The monoclonal antibody against
rTs-Pmy (mAb 7E2) was obtained using a conventional hybridoma
technique, and IgG was purified with HiTrap rProtein A affinity
columns (Amersham Biosciences, USA; data not shown).
Western blot analysis
Crude somatic extracts of T. spiralis ML, adult worms and NBL
were subjected to SDS-PAGE on a 12% acrylamide gel and
transferred onto a PVDF membrane (Millipore, USA). After being
blocked with a 5% (w/v) skim milk solution in Tris-buffered saline
(TBS) containing 0.05% Tween-20 (Sigma, USA) (TBS-T) for
1 hour at room temperature, the membrane was incubated with
mAb 7E2 at a concentration of 50–100 ng/mL in TBS-T.
Peroxidase-conjugated goat anti-mouse IgG (1:5,000; Sigma,
USA) was used as secondary antibody. The reaction was visualized
with enhanced chemiluminescence reagent (Pierce, USA) and
exposed to a BioMax film (Kodak, USA). In some experiments,
the Odyssey two color infrared imaging system was used according
to manufacturer’s instructions.
Immunolocalization
Immuno-gold labeling and electron microscopy. To
examine whether Ts-Pmy was located on the surface of the
parasite, the T. spiralis adult worms and NBL were fixed with 5%
paraformaldehyde and 0.1% glutaraldehyde in phosphate buffered
saline (PBS) for 72 hours at 4u, rinsed four times for 20 min each
in PBS and immuno-labeled with mAb 7E2 (1 mg/mL in PBS) and
gold-conjugated protein A (15 nm; Zymed Laboratories Inc.,
USA). Normal mouse serum at the same dilution was used as the
control. The immuno-labeled worms were postfixed in 1%
osmium tetroxide for 1 hour and dehydrated in a series of
alcohol and acetone before being embedded in Araldite and Epon.
Ultrathin sections were cut and stained with uranyl acetate and
Author Summary
Trichinellosis is a serious food borne parasitic disease
caused by the consumption of meat contaminated with
the infective larvae of Trichinella spiralis. The ability of the
tissue-dwelling parasite to evade the host complement
attack is essential for its survival and for establishing
infection in the host. This study describes the expression of
paramyosin, a muscular protein in invertebrates, on the
surface of Trichinella spiralis and its role in the defense
against the host complement attack as a survival strategy.
Using a specific antiserum, expression of Trichinella spiralis
paramyosin was detected on the outer membrane of the
adult worms and newborn larvae. Functional analysis
revealed that recombinant Trichinella spiralis paramyosin
protein strongly bound human complement components
C8 and C9 and inhibited the formation of the complement
membrane attack complex. Neutralization with a specific
antiserum greatly impaired the protective effect of
paramyosin on the viability and infectivity of Trichinella
spiralis newborn larva when under attack by complement.
These studies suggest that the outer membrane form of
Trichinella spiralis paramyosin plays an important role in
the evasion of the host complement attack and is
therefore a good target for vaccine and pharmaceutical
development.
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electron microscope (TEM) at 80 kV.
Immunofluorescence labeling. To determine if Ts-Pmy is
located on the surface of intact worms, whole adult worms and NBL of
T. spiralis were incubated with rabbit anti-rTs-Pmy antiserum or
normal rabbit serum for 3 hours at 37uC. After being washed three
times with RPMI 1640, the worms were treated with fluorescein
isothiocyanate-conjugated goat anti-rabbit IgG (Sigma) (1:100 in
RPMI 1640) for 1 hour. The worms were washed three times with
RPMI 1640 and examined under a fluorescence microscope (Leica,
Germany).
Complement-mediated killing of NBL in vitro
A total of 150 NBL released by adult female worms in culture
were pretreated with heat-inactivated (56u for 30 min) rabbit anti-
rTs-Pmy serum, the same serum pre-absorbed with rTs-Pmy or
heat-inactivated normal rabbit serum (NRS) (2, 20 or 40 mL) in a
total volume of 50 mL in a 96-well plate for 1 hour at room
temperature. Heat-inactivated rabbit antiserum against Ts87 was
used as a non-relevant antibody control (40 mL). Then, 100 mLo f
freshly pooled normal guinea pig serum (NGS) was added as a
complement source into each well, and the incubation was
continued for 24 hours in a 5% CO2 incubator at 37uC. Heat-
inactivated NGS (INGS) was added as a control. NBL mortality
was monitored under an inverted microscope based on motility
(The worms without any movement during 30 seconds of
observation and total stretch-out were scored as dead) and the
fluorescent staining of the DNA-binding dye SYTOX Green
(Invitrogen, USA) [27]. Experiments were run in triplicate.
Percent mortality was calculated as described elsewhere [21,28].
Passive transfer experiments of NBL
To determine the viability of NBL treated with anti-rTs-Pmy
serum and NGS, treated NBL were passively transferred into
BALB/c mice intravenously. Briefly, 2000 NBL per group were
pretreated with 100 mL of heat-inactivated anti-rTs-Pmy rabbit
serum, the same serum pre-absorbed with rTs-Pmy or heat-
inactivated NRS, and incubated with 400 mL of fresh NGS for
12 hours in a 5% CO2 incubator at 37uC. INGS were used as a
control. After being incubated with NGS or INGS, NBL were
washed with serum-free RPMI-1640, re-suspended in 0.25 ml of
PBS and injected into the lateral tail vein of BALB/c mice (8 mice
for each group) as described elsewhere [29]. Muscle larvae burdens
were collected and counted on the 26th day after injection [14].
Hemolytic assay of the alternative complement pathway
Complement-mediated lysis of rabbit erythrocytes (ER)w a s
performed via the alternative complement pathway as described by
Hong et al. [14]. To test whether Ts-Pmy acts as an inhibitor or
neutralizer of the complement activated by the alternative pathway,
fresh NGS (6%) were pre-incubated with various amounts of rTs-
Pmy (0, 10, 20 or 40 mg) in Mg-EGTA solution (5 mM MgCl2,
10 mM EGTA) for 30 min before adding the mixture to fresh,
washed ER (3610
8) in 0.1 mL of GVB (Veronal-buffered saline,
pH 7.4, containing 0.1% gelatin and 0.02% NaN3) for 30 min at
37uC. Lysis was stopped by adding 1 mL of cold GVB containing
10 mM EDTA. After being centrifuged at 4,4006g for 10 min at
4uC, the amount of hemoglobin released into the supernatant was
measured at 412 nm, and the percent lysis relative to the number of
cells lysed completely by water was calculated.
rTs-Pmy binding to C8 and C9
To determine whether rTs-Pmy binds to C8 and C9,purified
human C8,C9 (Merck,Germany) and non-relevant control BSA
(Sigma,USA) (1 mg each) were subjected to SDS-PAGE under
reducing conditions and transferred to a PVDF membrane. After
blocking with 5% milk in TBS-T, the membrane was incubated
with 10 mL of rTs-Pmy (5 mg/mL in TBS-T) for 3 hours at 37uC
and then with mAb 7E2 (50 ng/mL) for 1 hour at room
temperature. Peroxidase-conjugated goat anti-mouse IgG
(1:4,000; Sigma,USA) was used as the secondary antibody. Bands
were visualized with ECL (Pierce,USA). To determine the specific
binding of Ts-Pmy to C8 and C9, rTs-87 was used as a control to
react with C8 and C9 that had been transferred to a PVDF
membrane and probed with anti-Ts87 antiserum. For the
reciprocal experiment, the same amount of rTs-Pmy and BSA
(1 mg ) was transferred to a PVDF membrane and incubated with
C9 (0.5 mg/mL) for 2 hours at 37uC. After being washed with
TBS-T, the membrane was incubated with monoclonal anti-C9
antibody (1:4,000; Abcam, USA). To determine the competition
between the soluble C9 and blotted C9 for binding to Ts-Pmy,
rTs-Pmy was pre-incubated with C9 1:6 (w/w, 5 mg/mL of rTs-
Pmy and 30 mg/mL of C9) for 1 hour at 37uC before being
incubated with the membrane. The membrane was then reacted
with mAb 7E2 (50 ng/mL) and IRDye-800CW-conjugated goat
anti-mouse IgG (1:10,000; LI-COR, Germany).
C9 polymerization assays
To determine the effect of rTs-Pmy on Zn
2+-activated C9
polymerization [30], 3 mg of C9 was pre-incubated with various
amounts of rTs-Pmy at 37uC for 40 min and incubated with
50 mM ZnCl2 in 20 mM Tris buffer, pH 7.2 for 2 hours at 37uC.
Inhibition of C9 polymerization was shown by SDS-PAGE on a
2.5 to 25% acrylamide gradient gel under reducing conditions; the
gel was visualized by staining with Coomassie blue [31] or
analyzed by western blot with an anti-C9 antibody. A non-relevant
T. spiralis antigen Ts87 was used as a control.
rTs-Pmy inhibition of C9 polymerization on ER was performed
as reported by Tschopp et al. [32]. One hundred microliters of
normal human serum (NHS) supplemented with 5 mg of C9 was
pre-incubated with 30 mgo fr Ts-Pmy for 40 min at 37uC prior to
the addition of 3610
6 ER and continued incubation for 1 hour at
37uC. Lysed cells were washed three times with 3 mL of TBS
containing 5 mM EDTA (pH 8.0) and centrifuged for 20 min at
4,8006g at 4uC. Sediments were washed three times with 3 mL of
0.5 mM PBS (pH 8.0). Lysed cell pellets were analyzed by SDS-
PAGE under reducing conditions on a 2.5 to 15% gradient
acrylamide gel followed by either Coomassie blue staining or
Western blot with an anti-C9 antibody.
Statistical analysis
Results were expressed as the mean 6 SD. Differences between
groups were assessed by SPSS 10.0 (SPSS Inc., USA) using One-
Way ANOVA; p,0.05 was considered to be statistically significant.
Results
1. Expression and localization of Ts-Pmy in different
developmental stages of T. spiralis
The transcription of Ts-Pmy mRNA at different developmental
stages in T. spriralis was analyzed by RT-PCR with Ts-Pmy specific
primers. Ts-Pmy mRNA was transcribed in all developmental
stages (ML, NBL and adult worm; Figure 1A). The size of the
amplified cDNA fragments was 900 bp, which is the same size as
predicted by the DNA sequence. Western blot analysis showed
that an approximately 100 kDa band was recognized by mAb 7E2
in the somatic extracts the three developmental stages of T. spiralis
(ML, adult and NBL) (Figure 1B). The results show that Ts-Pmy is
expressed in all three developmental stages (ML, adult worm and
Trichinella spiralis Evade Host Complement Attack
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protein expression. Previously, immunofluorescent staining of
worm sections demonstrated that Ts-Pmy was expressed on the
surface of T. spiralis larvae [23]. Here, immunoelectron micros-
copy confirmed that Ts-Pmy was expressed on the outer
membrane of the cuticle of the NBL (Figure 1Ca) and adult
worm (Figure 1Cb). No significant staining was observed using
normal mouse serum at the same dilution (c and d). Using
immunofluorescence staining, Ts-Pmy was also observed on the
surface of intact adult worms (Figure 1Da) and NBL (Figure 1Db).
2. Enhanced complement-mediated killing of NBL treated
with anti- rTs-Pmy rabbit serum
To determine whether Ts-Pmy expressed on the parasite surface
protects NBL from being killed by the host complement, heat-
inactivated rabbit anti-rTs-Pmy serum was used to block Ts-Pmy
on the NBL. The antiserum- or normal rabbit serum-treated NBL
were challenged with the complement from fresh NGS. As shown
in Figure 2, after being blocked with anti-rTs-Pmy serum, NBL
viability was significantly decreased following incubation with
fresh NGS compared to those of the normal rabbit serum group.
The increase in complement-mediated killing of NBL blocked with
anti-rTs-Pmy serum was observed in an antiserum dose-dependent
manner. After being absorbed with rTs-Pmy, the anti-rTs-Pmy
serum had a minimal or non-existent effect on the complement-
mediated NBL killing. Incubating with rabbit antiserum against
recombinant Ts87, a specific T. spiralis secreted protein [33], that
is also located on the surface of worm [34], did not significantly
increase complement-mediated NBL killing (Figure 2).
3. In vivo decrease in the infectivity of NBL treated with
anti-rTs-Pmy rabbit serum and complement
The number of ML recovered from mouse muscle was reduced
by 95.1% for those NBL treated with anti-rTs-Pmy rabbit serum
Figure 1. Expression and immunolocalization of Ts-Pmy in the different developmental stages of T. spiralis. (A) RT-PCR showing mRNA
transcription of Ts-Pmy and GAPDH (control) from the different developmental stages of T. spiralis. Lane 1, DNA Marker; Lane 2, ML; Lane 4, adult
worm; Lane 6, NBL. Lanes 3, 5 and 7: non-reverse transcriptase negative controls. (B) Western blot detection of native Ts-Pmy and GAPDH (control)
expressed in different developmental stages of T. spiralis by specific antibodies with the Odyssey two color infrared imaging system. Lane 1, ML
extracts (8 mg); Lane 2, adult worm extracts (8 mg); Lane 3, NBL extracts (8 mg); Lane 4, purified rTs-Pmy (500 ng). (C). Electron micrographs of T.
spiralis immunolabeled with anti-rTs-Pmy mAb. NBL (a) and adult worm (b) were incubated with mouse anti-rTs-Pmy mAb or normal mouse serum (c
and d) and then with gold-conjugated protein A. Scale bars represent 0.2 mm. (D) Immunofluorescence micrographs of intact T. spiralis
immunolabeled with rabbit antiserum against Ts-Pmy. Intact whole adult worms (a) and NBL (b) were incubated with anti-rTs-Pmy rabbit serum or
normal rabbit serum (c and d) and then with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG. Scale bars represent 20 mm.
doi:10.1371/journal.pntd.0001225.g001
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rabbit serum/NGS 26 days after being transferred intravenously
into mice (Figure 3; p=0.006) . No significant reduction was
observed for ML developed from NBL treated with rTs-Pmy pre-
absorbed anti-rTs-Pmy serum. Heat-inactivated NGS (INGS) had
a smaller killing effect on NBL treated with anti-rTs-Pmy rabbit
serum (72.0% ML reduction) or with the same serum pre-
absorbed with rTs-Pmy (48.5% ML reduction) compared with the
normal rabbit serum control (Figure 3; p=0.048). These studies
further indicated that Ts-Pmy on the surface of NBL may protect
larvae from complement-mediated killing.
4. Inhibition of complement-mediated hemolysis by rTs-
Pmy
Complement-mediated ER lysis via the alternative pathway was
significantly inhibited by adding rTs-Pmy in a dose-dependent
manner (p,0.001). ER lysis was reduced by 55.7% when 10 mgo f
rTs-Pmy was added and by 91.9% when 40 mgo fr Ts-Pmy was
added (Figure 4).
Figure 2. Enhanced complement-mediated killing of T. spiralis NBL incubated with anti-rTs-Pmy rabbit serum. NBL were incubated with
different amounts of anti-rTs-Pmy rabbit serum, the same serum pre-absorbed with rTs-Pmy or normal rabbit serum (NRS) in a total volume of 50 mL
for 60 min before adding fresh normal guinea pig serum (NGS). In addition, 40 mL of anti-Ts87 rabbit serum was used as a control. Viability of NBL was
observed under an inverted microscope. Values are expressed as the means 6 SD for three independent experiments. *, statistically significant
differences (p,0.05) between anti-rTs-Pmy and anti-rTs-Pmy + rTs-Pmy or NGS control.
doi:10.1371/journal.pntd.0001225.g002
Figure 3. Recovered ML developed from NBL treated with anti-
rTs-Pmy rabbit serum and NGS. Two thousand NBL were incubated
with anti-rTs-Pmy rabbit serum, the same serum absorbed with rTs-Pmy
or NRS (100 mL), followed by NGS or INGS. Treated NBL were then
injected into BALB/c mice. ML were recovered from the muscle tissues
of mice 26 days after injection. Data represent the means 6 SD from
three independent experiments. **, indicate statistically significant
differences (p,0.01) between the antiserum-treated/NGS group and
protein absorbed serum/NGS or NRS/NGS group; * indicate statistically
significant differences (p=0.048) between the antiserum-treated/INGS
group and NRS/INGS group (n=8 in each group).
doi:10.1371/journal.pntd.0001225.g003
Figure 4. Inhibition of complement-mediated lysis of ER by
rTs-Pmy. Various amounts of rTs-Pmy (0, 10, 20 or 40 mg) were
incubated with fresh NGS(6%), and then fresh ER were added
(3610
8 cells). The amount of hemoglobin released into the supernatant
was measured at 412 nm, and the percent lysis was calculated. The
results are shown as the means 6 SD for three independent
experiments.
doi:10.1371/journal.pntd.0001225.g004
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After being transferred to a membrane, the human C8 and C9
were probed with rTs-Pmy and detected with anti-rTs-Pmy mAb.
Western blot analysis demonstrated that rTs-Pmy strongly bound
to human C8 (a,b chains) and C9 (Figure 5B). The amount of rTs-
Pmy bound to the immobilized C9 was dramatically decreased
(Figure 5E) after being absorbed with soluble C9. Reciprocally, the
binding of C9 to rTs-Pmy immobilized on a membrane was also
demonstrated by incubating the membrane with soluble C9 and
detecting with an anti-C9 mAb (Figure 6). In the control
experiment, the same amount of recombinant Ts87 did not bind
to C8 and C9 (Figure 5D).
6. Inhibition of C9 polymerization and poly-C9 formation
on the ER by rTs-Pmy
C9 polymerization leads to the creation of transmembrane
channels that are critical for complement-mediated cytolysis [35].
To determine whether Ts-Pmy inhibits the Zn
2+-induced C9
polymerization, C9 was mixed with various amounts of rTs-Pmy
and then incubated with 50 mM ZnCl2. As shown in Figure 7, rTs-
Pmy inhibited Zn
2+-induced C9 polymerization in a dose-
dependent manner. When the amount of rTs-Pmy was increased
to 10 mg, it completely inhibited the polymerization of 3 mgo fC 9
(Figure 7, lane 6). The same amount of recombinant Ts87 did not
inhibit C9 polymerization. In addition, rTs-Pmy inhibited the
Figure 5. Determination of rTs-Pmy binding to human C8 and C9. Human C8 (1 mg, Lane 1) and C9 (1 mg, Lane 3) and non-relevant BSA
control (1 mg, Lane 2) were subjected to SDS-PAGE under reducing conditions and (A) stained with Coomassie blue, and then (B) transferred onto a
PVDF membrane, incubated with rTs-Pmy (5 mg/mL) and detected with anti-rTs-Pmy mAb (50 ng/mL). The same materials that were added, plus non-
relevant control protein rTs87 (300 ng; Lane 4) were subjected to SDS-PAGE and (C) stained with Coomassie blue, and (D) transferred to an NC
membrane, incubated with rTs87 (5 mg/mL) and detected with anti-Ts87 rabbit serum (1:4000). To determine the binding competition between
soluble and immobilized C9 to rTs-Pmy, rTs-Pmy (5 mg/mL) was pre-incubated with C9 (30 mg/mL) for 1 hour before incubation with the membrane
containing with C9 (1 mg) and BSA (1 mg), and was detected with anti-rTs-Pmy mAb (50 ng/mL) (E). M:standard protein marker.
doi:10.1371/journal.pntd.0001225.g005
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the ER (Figure 8, lane 3).
Discussion
Recent studies have shown that the complement system plays a
role in granulocyte recruitment and parasite impairment in
nematode infectionprior to antibody production[36]. Complement
components have been implicated in the killing of Strongyloides
stercoralis larvae [37] and Schistosoma mansoni schistosomula [21]. The
ability to evade complement attack is essential for the survival of
tissue-dwelling nematodes within hosts. Many parasites, especially
those living in or in contact with blood, seem to have developed
parallel routes to escape complement attack [38]. T. spiralis infective
larvae (ML), adults and NBL are able to bind to the complement
components [14] and evade complement-mediated killing [15].
However, the mechanism by which T. spiralis evades complement-
mediated killing is still not completely understood.
Paramyosin is an essential muscle protein in invertebrates,
forming the core of thick myofilaments that determine the length
and stability of muscles [17]. It has been suggested that the surface
expression of paramyosin by Schistosoma mansoni [20] and Taenia
solium [39] may inhibit the complement cascade of the immune
system. Thus, in the present study, we examined the expression
and localization of Ts-Pmy in the three developmental stages of T.
spiralis and showed that Ts-Pmy is present on the outer membrane
of the cuticle of the adults and NBL of T. spiralis. Our results were
consistent with other observations that identified paramyosin in
the tegument and on the surface of Schistosoma mansoni, Schistosoma
japonicum [19], Echinococcus granulosus [40], Taenia solium [39] and
Fasciola hepatica [41]. The existence of a surface-exposed form of
paramyosin suggests a role as a potential modulator of the host
immune system. It was previously observed that paramyosin on
the surface of helminth parasites bound to the Fc of IgG [19] and
IgA [42], collagen and at least three complement components,
C1q [18], C8 and C9 [20]. The fact that Ts-Pmy is expressed on
Figure 7. Inhibition of Zn
2+-induced C9 polymerization by rTs-Pmy. C9 (3 mg) was pre-mixed with various amounts of rTs-Pmy (Lane 2, 0 mg;
Lane 6, 10 mg; Lane 7, 2.5 mg and Lane 8, 1 mg) or rTs87 (Lane 3, 10 mg; Lane 4, 2.5 mg) and incubated with 50 mM ZnCl2. Lane 5, blank C9 without
adding Zn
2+ as a negative control. Lane 1, standard protein marker. The reaction mixtures were analyzed by SDS-PAGE and Western blot with anti-C9
mAb for Lane 8 as shown in Lane 9.
doi:10.1371/journal.pntd.0001225.g007
Figure 6. Binding of soluble C9 to immobilized rTs-Pmy. BSA
(Lane 2) and rTs-Pmy (Lane 3) were transferred to a PVDF membrane,
incubated with soluble C9 (left) or PBS only (right) and detected with
monoclonal anti-C9 antibody.
doi:10.1371/journal.pntd.0001225.g006
Figure 8. Inhibition of poly-C9 deposition on the surface of ER
by rTs-Pmy. The NHS was incubated with rTs-Pmy (Lane 3) or with
buffer only (Lane 2) before adding fresh ER. Lane 1, standard protein
marker. Membrane debris of lysed ER was analyzed by SDS-PAGE under
reducing conditions and Western blotting with anti-C9 mAb.
doi:10.1371/journal.pntd.0001225.g008
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first line of defense against the host immune response.
Our data confirmed that surface-exposed Ts-Pmy binds to
complement C8 and C9, which are important components of the
complement activation cascade and comprise the membrane
attack complex (MAC) [43]. Polymerization of C9 induced by
Zn
2+ was highly inhibited by rTs-Pmy, indicating that the
assembly of the MAC was impaired. The alternative complement
pathway that activates the complement complex or poly-C9 on the
rabbit erythrocytes (ER) was also greatly inhibited by rTs-Pmy.
These studies suggest that Ts-Pmy binding to C8 and C9 inhibits
the assembly and formation of the MAC, creating an effective
strategy for the parasite to evade complement attack [28]. Similar
strategies are also adopted by Schistosoma mansoni [28], Entamoeba
hisolytica [44], Herpesvirus saimiri [45] and Trypanosoma cruzi [46].
Functional analysis in this study revealed that rTs-Pmy inhibited
the lysis of ER triggered by guinea pig serum, indicating that the
binding of Ts-Pmy to C8/C9 or other complement elements
inhibits the complement activation pathways. Whole T. spiralis
worms also inhibited of complement-mediated hemolysis [14],
suggesting that native Ts-Pmy or other modulating molecules on
the surface of the worm might have similar functions as
complement inhibitors. Such observations are consistent with the
findings of other studies of paramyosin in Schistosoma mansoni
[20,21].
Additional evidences from this study show that native Ts-Pmy
on the surface of T. spiralis effectively protected NBL from attack
by host complements. Blocking Ts-Pmy on the surface of T. spiralis
with anti-rTs-Pmy antiserum reduce of NBL viability when under
attack by complement in vitro. In vivo passive transfer experiments
with NBL treated with anti-Ts-Pmy antiserum and NGS also
showed a significant reduction in the number of NBL that
developed into ML in mouse muscle, indicating that the infectivity
of these larvae after Ts-Pmy blocked by antibodies was seriously
impaired.
Our studies suggest that the outer membrane form of
paramyosin expressed by T. spiralis has a role in host immuno-
modulation, presumably by inhibiting the formation of the MAC
and thereby protecting the parasite from being damaged by
activated complement. This modulation is an effective survival
strategy for T. spiralis to live within its host. Disruptions of the
immunomodulatory function of Ts-Pmy could be explored as an
alternative strategy to control T. spiralis infection. As a result, T.
spiralis paramyosin is under further evaluation as a potential
laboratory reagent to study host complement function and as a
potential vaccine antigen. The specific epitope in Ts-Pmy that
reacts with the complement or elicits protective immunity is
currently being defined.
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